Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano Labs (NA) Other Accumulated Expenses (2021 - 2025)

Nano Labs' Other Accumulated Expenses history spans 5 years, with the latest figure at $7.7 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $7.7 million for Q4 2025, down 18.12% from a year ago — trailing twelve months through Dec 2025 was $7.7 million (down 18.12% YoY), and the annual figure for FY2025 was $7.7 million, down 17.31%.
  • Other Accumulated Expenses for Q4 2025 was $7.7 million at Nano Labs, down from $9.4 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $9.4 million in Q4 2024 to a low of $1.1 million in Q4 2021.
  • The 5-year median for Other Accumulated Expenses is $5.5 million (2022), against an average of $5.1 million.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 411.99% in 2022, then crashed 65.89% in 2023.
  • Year by year, Other Accumulated Expenses stood at $1.1 million in 2021, then skyrocketed by 411.99% to $5.5 million in 2022, then crashed by 65.89% to $1.9 million in 2023, then skyrocketed by 394.84% to $9.4 million in 2024, then dropped by 18.12% to $7.7 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $7.7 million, $9.4 million, and $1.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.